Celldom, Inc.

Durham, NC · Medtech · Private

Microfluidic platform combining image-based phenotyping with single-cell transcriptomics using DNA-barcoded trap arrays

Grants
$7.1M
8 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
9
1 granted · 8 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity$224,907
Federal grantDepartment of Health and Human Services · Phase II · High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity$1,480,039
Federal grantDepartment of Health and Human Services · Phase I · Platform for genotyping and phenotyping each cell in a high throughput assay$298,559
Federal grantDepartment of Health and Human Services · Phase II · High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity$728,478
Federal grantDepartment of Health and Human Services · Phase II · Platform for genotyping and phenotyping each cell in a high throughput assay$1,663,928
Federal grantDepartment of Health and Human Services · Phase II · Platform for genotyping and phenotyping each cell in a high throughput assay$831,964
Federal grantDepartment of Health and Human Services · Phase II · High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures$938,647
Federal grantDepartment of Health and Human Services · Phase II · High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures$908,687
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2278Frontier Diagnostics, LLC——
2279GLYCODOTS, LLC——
2280GLOBAL BIOMEDICAL TECHNOLOGIES, LLC—$1.0M
2281Celldom, Inc.——
2282EARLY ALZHEIMER'S DIAGNOSTICS LLC——
2283Articulate Biosciences, LLC——
2284CAMERAD TECHNOLOGIES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 9
  • Device And Method For Cell-based Drug Screeninggranted
  • Protein Linker System For Conjugation And Release Of Oligonucleotidesapplication
  • Fluorescent Barcoding Of Microparticlesapplication
  • Methods and Devices for Single Cell Barcodingapplication
  • Methods and Devices for Single Cell Barcodingapplication
  • Methods And Devices For Cell Transfection And Gene Expression Assaysapplication
  • Methods And Devices For Single Cell Barcodingapplication
  • Fluorescent Barcoding Of Microparticlesapplication
  • Methods And Devices For Single Cell Barcodingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.